Designation in paper | ATC-Codesystem |
---|---|
Insulin | A10A: Insulins and analogues |
Oral antidiabetes medication | A10B: Blood glucose lowering drugs, excluding insulins |
Biguanides | A10BA: Biguanides |
Sulfonylureas | A10BB: Sulfonylureas |
Antidiabetes combinations | A10BD: Combinations of oral blood glucose lowering drugs |
α-Glucosidase inhibitors | A10BF: Alpha glucosidase inhibitors |
Thiazolidinediones | A10BG: Thiazolidinediones |
DPP-4 inhibitors | A10BH: Dipeptidyl peptidase 4 (DPP-4) inhibitors |
Meglitinides | A10BX: Other blood glucose lowering drugs, excluding insulins |
Vitamin K antagonists (VKA) | B01AA: Vitamin K antagonists |
Warfarin | B01AA03: Warfarin |
ADP receptor antagonists | B01AC04: Clopidogrel, B01AC05: Ticlopidine, B01AC22: Prasugrel, B01AC24: Ticagrelor |
Oral anticoagulations (OAC) | VKA & NOAC |
Non-vitamin K antagonist oral anticoagulants (NOAC) | Dabigatran, Rivaroxaban, and Apixaban |
Rivaroxaban | B01AF01: Rivaroxaban |
Apixaban | B01AF02: Apixaban |
Dabigatran | B01AE07: Dabigatran etexilate |
Aspirin | B01AC06 ASS |
Dipyridamole | B01AC07: Dipyridamole |
Digoxin | C01AA05: Digoxin |
Diuretics | C03: Diuretics |
Thiazide diuretics | C03A: Low-ceiling diuretics, thiazides |
Hydrochlorothiazide | C03AA03: Hydrochlorothiazide |
Loop diuretics | C03C: High-ceiling diuretics |
Furosemide | C03CA01: Furosemide |
Hydrochlorothiazide; triamterene | C03EA01: Hydrochlorothiazide and potassium-sparing agents |
β-blockers | C07: Beta blocking agents |
Metoprolol | C07AB02: Metoprolol |
Atenolol | C07AB03: Atenolol |
Carvedilol | C07AG02: Carvedilol |
Calcium channel blockers | C08: Calcium channel blockers |
Amlodipine | C08CA01: Amlodipine |
Nifedipine | C08CA05: Nifedipine |
Verapamil | C08DA01: Verapamil |
Diltiazem | C08DB01: Diltiazem |
RAAS | C09: Agents acting on the renin-angiotensin system |
Renin-angiotensin system inhibitors: | C09A: ACE inhibitors, plain |
Lisinopril | C09AA03: Lisinopril |
Lisinopril; hydrochlorothiazide | C09BA03: Lisinopril and diuretics |
Angiotensin receptor blockers | C09C: Angiotensin II antagonists, plain |
Losartan | C09CA01: Losartan |
Valsartan | C09CA03: Valsartan |
Olmesartan | C09CA08: Olmesartan medoxomil |
Non-steroidal antiinflammatory drugs: | M01A: Anti-inflammatory and antirheumatic products, non-steroids |